Les titres de référence

Publi Blood-septembre 2015



article



Article publié le 24/09/2015 par Administrateur
Dernière modification le 15/07/2016 par Administrateur



Liste de référence



Certains des articles sont en lien ci-dessous 

 

Reference List

 

      1.   Abdallah M, Genereau T, Donadieu J, Emile JF, Chazouilleres O, Gaujoux-Viala C et al.: Langerhans' cell histiocytosis of the liver in adults. Clin Res Hepatol Gastroenterol 2011, 35: 475-481.

      2.   Akkari V, Donadieu J, Piguet C, Bordigoni P, Michel G, Blanche S et al.: Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant 2003, 31: 1097-1103.

      3.   Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N et al.: Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003, 39: 2341-2348.

      4.   Barthez MA, Araujo E, Donadieu J: Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol 2000, 15: 150-156.

      5.   Bernard F, Thomas C, Bertrand Y, Munzer M, Landman PJ, Ouache M et al.: Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. Eur J Cancer 2005, 41: 2682-2689.

      6.   Blouin P, Yvert M, Arbion F, Pagnier A, Emile JF, Eitenschenck L et al.: Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC. Pediatr Blood Cancer 2010, 55: 757-760.

      7.   Donadieu J, Rolon MA, Pion I, Thomas C, Doz F, Barkaoui M et al.: Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab 2004, 89: 604-609.

      8.   Donadieu J, Piguet C, Bernard F, Barkaoui M, Ouache M, Bertrand Y et al.: A new clinical score for disease activity in Langerhans cell histiocytosis. Pediatr Blood Cancer 2004, 43: 770-776.

      9.   Donadieu J: Langerhans cell histiocytosis: portrait of a disease as a rare tumour. Eur J Cancer 2004, 40: 1465-1466.

    10.   Donadieu J, Rolon MA, Thomas C, Brugieres L, Plantaz D, Francois EJ et al.: Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr 2004, 144: 344-350.

    11.   Donadieu J: A single-centre study can improve our knowledge of a rare disease! As exemplified by studies in Langerhans' cell histiocytosis. Acta Paediatr 2005, 94: 1010-1011.

    12.   Donadieu J, Egeler M, Pritchard J: Langerhans cell histiocytosis: a clinical update. In Histiocytic Disorders of Children and Adults. Edited by Weitzman S, Egeler M. 2005:95-129.

    13.   Donadieu J, Guyot-Goubin A, Clavel J, Thomas C: [Clinical presentation and epidemiology of childhood Langerhans cell Histiocytosis]
33.
Arch Pediatr 2008, 15: 520-522.

    14.   Emile JF, Peuchmaur M, Fraitag S, Bodemer C, Brousse N: Immunohistochemical detection of granulocyte/macrophage colony-stimulating factor in Langerhans' cell histiocytosis. Histopathology 1993, 23: 327-332.

    15.   Emile JF, Fraitag S, Leborgne M, De Prost Y, Brousse N: Langerhans' cell histiocytosis cells are activated Langerhans' cells. J Pathol 1994, 174: 71-76.

    16.   Emile JF, Tartour E, Brugieres L, Donadieu J, Le Deist F, Charnoz I et al.: Detection of GM-CSF in the sera of children with Langerhans' cell histiocytosis. Pediatr Allergy Immunol 1994, 5: 162-163.

    17.   Emile JF, Fraitag S, Andry P, Leborgne M, Lellouch-Tubiana A, Brousse N: Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells. Virchows Arch 1995, 427: 125-129.

    18.   Emile JF, Wechsler J, Brousse N, Boulland ML, Cologon R, Fraitag S et al.: Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol 1995, 19: 636-641.

    19.   Emile JF, Fraitag S, Leborgne M, De Prost Y, Brousse N: In situ expression of activation markers by Langerhans' cells containing GM-CSF. Adv Exp Med Biol 1995, 378:101-3.: 101-103.

    20.   Emile JF, Geissmann F, Martin OC, Radford-Weiss I, Lepelletier Y, Heymer B et al.: Langerhans cell deficiency in reticular dysgenesis. Blood 2000, 96: 58-62.

    21.   Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, Littman DR et al.: A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311: 83-87.

    22.   Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A et al.: A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001, 138: 728-734.

    23.   Gadner H, Grois N, Potschger U, Minkov M, Arico M, Braier J et al.: Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 2007.

    24.   Geissmann F, Thomas C, Emile JF, Micheau M, Canioni D, Cerf-Bensussan N et al.: Digestive tract involvement in Langerhans cell histiocytosis. The French Langerhans Cell Histiocytosis Study Group. J Pediatr 1996, 129: 836-845.

    25.   Geissmann F, Emile JF, Andry P, Thomas C, Fraitag S, De Prost Y et al.: Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J Pathol 1997, 181: 301-304.

    26.   Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O: Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998, 187: 961-966.

    27.   Geissmann F, Thomas C: Etat des connaissances concernant la présentation clinique, la physiopathologie et le traitement de l'histiocytose langerhansienne (histiocytosis X)]. Arch Pediatr 1999, 6 Suppl 2:414s-416s.: 414s-416s.

    28.   Geissmann F, Lepelletier Y, Fraitag S, Valladeau J, Bodemer C, Debre M et al.: Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001, 97: 1241-1248.

    29.   Geissmann F, eu-Nosjean MC, Dezutter C, Valladeau J, Kayal S, Leborgne M et al.: Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002, 196: 417-430.

    30.   Geissmann F, Revy P, Brousse N, Lepelletier Y, Folli C, Durandy A et al.: Retinoids regulate survival and antigen presentation by immature dendritic cells. J Exp Med 2003, 198: 623-634.

    31.   Geissmann F, Jung S, Littman DR: Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19: 71-82.

    32.   Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ et al.: Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005, 3: e113.

    33.   Georget-Bouquinet E, Madhi F, Delacourt C, Billette T, Debray D, Reinert P et al.: [Inaugural trunk dystonia revealing Langerhans cell histiocytosis]. Arch Pediatr 2009, 16: 1021-1023.

    34.   Grois N, Fahrner B, Arceci RJ, Henter JI, McClain K, Lassmann H et al.: Central nervous system disease in Langerhans cell histiocytosis. J Pediatr 2010, 156: 873-81, 881.

    35.   Guyot-Goubin A, Donadieu J, Barkaoui M, Bellec S, Thomas C, Clavel J: Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer 2008, Epub ahead of print.

    36.   Heritier S, Le MM, Jaubert F, Bigorre M, Gillibert-Yvert M, de Court et al.: Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009. Orphanet J Rare Dis 2010, 5: 3.

    37.   Idbaih A, Donadieu J, Barthez MA, Geissmann F, Bertrand Y, Hermine O et al.: Retinoic acid therapy in "degenerative-like" neuro-langerhans cell histiocytosis: a prospective pilot study. Pediatr Blood Cancer 2004, 43: 55-58.

    38.   Jeziorski E, Senechal B, Molina TJ, Devez F, Leruez-Ville M, Morand P et al.: Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis
28.
PLoS One 2008, 3: e3262.

    39.   Marchand I, Barkaoui MA, Garel C, Polak M, Donadieu J: Central Diabetes Insipidus as the Inaugural Manifestation of Langerhans Cell Histiocytosis: Natural History and Medical Evaluation of 26 Children and Adolescents. J Clin Endocrinol Metab 2011, 96: E1352-E1360.

    40.   Martin-Duverneuil N, Idbaih A, Hoang-Xuan K, Donadieu J, Genereau T, Guillevin R et al.: MRI features of neurodegenerative Langerhans cell histiocytosis. Eur Radiol 2006.

    41.   Minkov M, Steiner M, Potschger U, Arico M, Braier J, Donadieu J et al.: Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry. J Pediatr 2008, 153: 700-5, 705.

    42.   Ribeiro MJ, Idbaih A, Thomas C, Remy P, Martin-Duverneuil N, Samson Y et al.: (18)F-FDG PET in neurodegenerative Langerhans cell histiocytosis : Results and potential interest for an early diagnosis of the disease. J Neurol 2008.

    43.   Roger G, Dupre M, Leboulanger N, Godey B, Thomas C, Gandemer V et al.: Cholesteatoma secondary to temporal bone involvement by Langerhans cell histiocytosis: a complication amenable to curative surgery. Otol Neurotol 2009, 30: 190-193.

    44.   Slacmeulder M, Geissmann F, Lepelletier Y, Fournet JC, Brousse N, Thomas C et al.: No association between Langerhans cell histiocytosis and human herpes virus 8. Med Pediatr Oncol 2002, 39: 187-189.

    45.   Steiner M, Matthes-Martin S, Attarbaschi A, Minkov M, Grois N, Unger E et al.: Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 2005, 36: 215-225.

    46.   Tazi A, Nioche S, Chastre J, Smiejan JM, Hance AJ: Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage. Am J Respir Cell Mol Biol 1991, 4: 140-147.

    47.   Tazi A, Bonay M, Grandsaigne M, Battesti JP, Hance AJ, Soler P: Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am Rev Respir Dis 1993, 147: 1531-1536.

    48.   Tazi A, Bonay M, Bergeron A, Grandsaigne M, Hance AJ, Soler P: Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 1996, 51: 611-614.

    49.   Tazi A, Montcelly L, Bergeron A, Valeyre D, Battesti JP, Hance AJ: Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 1998, 157: 2007-2010.

    50.   Tazi A, Moreau J, Bergeron A, Dominique S, Hance AJ, Soler P: Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol 1999, 163: 3511-3515.

    51.   Tazi A, Soler P, Hance AJ: Adult pulmonary Langerhans' cell histiocytosis. Thorax 2000, 55: 405-416.

    52.   Tazi A, Jereon T, Hiltermann N, Vassallo R: Adult lung histiocytosis. In Histiocytic Disorders of Children and Adults. Edited by Weitzman S, Egeler M. 2005:187-207.

    53.   The French Langerhans' Cell Histiocytosis Study Group:  A multicentre retrospective survey of Langerhans' cell histiocytosis : 348 cases observed between 1983 and 1993. Arch Dis Child 1996, 75: 17-24.

    54.   Thomas C, Donnadieu J, Emile JF, Brousse N: Histiocytose langerhansienne. Arch Pediatr 1996, 3: 63-69.

    55.   Thomas C, Donadieu J: [Langerhans'cell histiocytosis: therapeutic approach]. Arch Pediatr 2008, 15: 529-531.

    56.   Viollet L, Commare-Nordmann MC, Langlais J, Polak M, Donadieu J: Maladie de Basedow'chez un adolescent avec une histiocytose X. Arch Pediatr 1997, 4: 656-658.

    57.   Weitzman S, Braier J, Donadieu J, Egeler RM, Grois N, Ladisch S et al.: 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society. Pediatr Blood Cancer 2009, 53: 1271-1276.

 

 Articles du Groupe français avec liens (jusqu'en 2003) :

 

  1. Akkari V., Donadieu J., Piguet C., Bordigoni P., Michel G., Blanche S., Casanova JL., Thomas C., Vilmer E., Fischer A., Bertrand Y. (2003)
    Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans Cell Study Group.
    Bone Marrow Transplant 31 : 1097-1103.
  2. Tordjman R., Lepelletier Y., Lemarchandel V., Cambot M., Gaulard P., Hermine O., Romeo P.H. (2002)
    A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response.
    Nat. Immunol 3 : 477-482.
  3. Slacmeulder M., Geissmann F., Lepelletier Y., Fournet J.-C., Brousse N., Thomas C., Donadieu J., Gessain A. (2002)
    No association between Langerhans cell histiocytosis and human herpes virus 8.
    Med. Pediatr. Oncol. 39 : 187-189.
  4. Bernard F., Thomas C., Emile J.-F., Hercus T., Cassinat B., Chomienne C., Donadieu J. (2002)
    Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia.
    Blood 99 : 2615-2616.
  5. Geissmann F., Lepelletier Y., Fraitag S., Valladeau J., Bodemer C., Debre M., Leborgne M., Saeland S., Brousse N. (2001b)
    Differentiation of Langerhans cells in Langerhans cell histiocytosis.
    Blood 97 : 1241-1248.
  6. Barthez M.-A., Araujo E., Donadieu J. (2000)
    Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study.
    J. Child. Neurol. 15 : 150-156.
  7. Bouloc A., Boulland M.-L., Geissmann F., Fraitag S., Andry P., Teillac D., Bensussan A., Revuz J., Boumsell L., Wechsler J., Bagot M. (2000)
    CD101 expression by Langerhans cell histiocytosis cells.
    Histopathology 36 : 229-232.
  8. Tazi A., Soler P., Hance A.-J. (2000)
    Adult pulmonary Langerhans' cell histiocytosis.
    Thorax 55: 405-416.
  9. Tazi A., Moreau J., Bergeron A., Dominique S., Hance A.-J., Soler P. (1999a)
    Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells : importance of the cytokine microenvironment.
    J. Immunol. 163 : 3511-3515.
  10. Tazi A., Soler P., Hance A.-J. (1999b)
    [Pathogenesis of adult pulmonary Langerhans-cell histiocytosis]. Rev. Mal. Respir. 16 : 151-159.
  11. Geissmann F. (1999)
    [Current knowledge of the physiology and physiopathology of dendritic cells]. Rev. Med. Interne 20 : 441-444.
  12. Geissmann F., Revy P., Regnault A., Lepelletier Y., Dy M., Brousse N., Amigorena S., Hermine O., Durandy A. (1999)
    TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162 : 4567-4575.
  13. Geissmann F., Thomas C. (1999)
    [Current status of clinical knowledge, physiopathology, and treatment of Langerhans histiocytosis (histiocytosis X)]. Arch. Pediatr. 6 Suppl 2 :414s-416s.
  14. Brabencova E., Tazi A., Lorenzato M., Bonay M., Kambouchner M., Emile J.-F., Hance A.-J., Soler P. (1998)
    Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells. Am. J. Pathol. 152 : 1143-1149.
  15. Geissmann F., Patey-Mariaud de Serre., Brousse N. (1998a)
    [Cellular adhesion molecules in hematologic disease]. (Molécules d'adhérence cellulaire en hématopathologie).Ann. Pathol. 18 : 253-260.
  16. Geissmann F., Prost C., Monnet J.-P., Dy M., Brousse N., Hermine O. (1998b)
    Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187: 961-966.
  17. Geissmann F., Ruskone-Fourmestraux A., Hermine O., Bourquelot P., Belanger C., Audouin J., Delmer A., Macintyre E.A., Varet B., Brousse N. (1998c)
    Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma.
    Am. J. Pathol. 153 : 1701-1705.
  18. Tazi A., Montcelly L., Bergeron A., Valeyre D., Battesti J.-P., Hance A.-J. (1998)
    Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Am. J. Respir. Crit. Care Med. 157 : 2007-2010.
  19. Kambouchner M., Colby T.V., Domenge C., Battesti J.-P., Soler P., Tazi A. (1997)
    Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone. Histopathology 30 : 353-358.
  20. Geissmann F., Emile J.-F., Andry P., Thomas C., Fraitag S., De Prost Y., Brousse N. (1997)
    Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J. Pathol. 181 : 301-304.
  21. Viollet L., Commare-Nordmann M.-C., Langlais J., Polak M., Donadieu J. (1997)
    [Basedow's disease in an adolescent with histiocytosis X]. Arch. Pediatr. 4 : 656-658.
  22. Geissmann F., Thomas C., Emile J.-F., Micheau M., Canioni D., Cerf-Bensussan N., Lazarovits A.I., Brousse N. (1996)
    Digestive tract involvement in Langerhans cell histiocytosis. The French Langerhans Cell Histiocytosis Study Group. J. Pediatr. 129 : 836-845.
  23. Tazi A., Bonay M., Bergeron A., Grandsaigne M., Hance A.-J., Soler P. (1996)
    Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 51 : 611-614.
  24. The french langerhans cell study group. (1996).
    A multicentre retrospective survey of langerhans cell histiocytosis : 348 cases observed between 1983 and 1993. Arch. Dis. Child, 75 : 17-24.
  25. Emile J.F., Donadieu J., Thomas C., Brousse N. (1995)
    [Langerhans-cell histiocytosis. Recent data on diagnosis and physiopathology]. Ann. Pathol. 15 : 252-259.
  26. Soler P., Tazi A., Hance A.-J. (1995)
    Pulmonary Langerhans cell granulomatosis. Curr. Opin. Pulm. Med. 1 : 406-416.
  27. Emile J.-F., Tartour E., Brugieres L., Donadieu J., Le Deist F., Charnoz I., Fischer A., Fridman W.H., Brousse N. (1994)
    Detection of GM-CSF in the sera of children with Langerhans' cell histiocytosis. Pediatr. Allergy Immunol. 5 : 162-163.
  28. Tazi A., Bonay M., Grandsaigne M., Battesti J.-P., Hance A.-J., Soler P. (1993a)
    Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am. Rev. Respir. Dis. 147 : 1531-1536.
  29. Tazi A., Bouchonnet F., Grandsaigne M., Boumsell L., Hance A.-J., Soler P. (1993b)
    Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J. Clin. Invest. 91 : 566-576.
  30. Soler P., Tazi A., Basset F., Hance A.-J. (1991)
    [Pulmonary dendritic cells]. Rev. Mal. Respir. 8 : 191-196.


Article publié le 01/01/2008 par Administrateur
Dernière modification le 06/12/2011 par Administrateur